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Abstract—Four-point electrode systems are commonly used
for electric impedance measurements of biomaterials and
tissues. We introduce a 2-point system to reduce electrode
polarization for heterogeneous measurements of vascular
wall. Presence of endoluminal oxidized low density lipopro-
tein (oxLDL) and lipids alters the electrochemical impedance
that can be measured by electrochemical impedance spec-
troscopy (EIS). We developed a catheter-based 2-point
micro-electrode conﬁguration for intravascular deployment
in New Zealand White rabbits. An array of 2 ﬂexible round
electrodes, 240 lm in diameter and separated by 400 lm was
microfabricated and mounted on an inﬂatable balloon
catheter for EIS measurement of the oxLDL-rich lesions
developed as a result of high-fat diet-induced hyperlipidemia.
Upon balloon inﬂation, the 2-point electrode array con-
formed to the arterial wall to allow deep intraplaque
penetration via alternating current (AC). The frequency
sweep from 10 to 300 kHz generated an increase in capac-
itance, providing distinct changes in both impedance (X) and
phase (/) in relation to varying degrees of intraplaque lipid
burden in the aorta. Aortic endoluminal EIS measurements
were compared with epicardial fat tissue and validated by
intravascular ultrasound and immunohistochemistry for
plaque lipids and foam cells. Thus, we demonstrate a new
approach to quantify endoluminal EIS via a 2-point stretch-
able electrode strategy.
Keywords—Electrochemical impedance spectroscopy, Flexi-
ble electronics, Lipid-rich plaque, Atherosclerosis.
INTRODUCTION
Electrochemical impedance spectroscopy (EIS)
measures charges stored in tissues by electrical im-
pedance (Z) developed in response to applied alter-
nating current (AC). EIS is the macroscopic
representation of the electric ﬁeld and current density
distribution within the experimented samples. Such
distribution can be described with Maxwell’s equa-
tions, which, under the quasi-electrostatic limit, re-
duces to5:
r  rruð Þ ¼ 0; ð1Þ
where r ¼ rT þ jxeT, and rT and eT represent the
conductivity and permittivity of the sample, respec-
tively, x is the angular frequency, j ¼ ﬃﬃﬃﬃﬃﬃ1p , u denotes
the voltage distribution. Current density, J
* ¼ rE*; is
calculated with known distribution of electric ﬁeld, E
*
.
Finally, impedance of the sample, Z, based on Max-
well’s equations, is expressed as:
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Z ¼ Du
R
S J
*  dS
; ð2Þ
where S denotes the electrode-tissue interface area, Du
represents the voltage difference across the two mea-
suring electrodes.
Fat-free tissue is known to be a viable electrical con-
ductor for its high water (approximately 73%) and elec-
trolytes (ions and proteins) content. However, fat tissue is
anhydrous and thus, a poor conductor. The high lipid
content, including negatively charged active lipids such as
oxidized lowdensity lipoprotein (oxLDL)27 and foamcells
present in the plaque change the endoluminal electro-
chemical properties that can be measured by EIS.17,28–30
The application of microelectrode sensor measures
the non-Faraday impedance due to the interface
capacitance and non-homogeneities of fatty streaks or
pre-atherosclerotic lesions that harbor oxLDL and
foam cell inﬁltrates. Suselbeck et al. measured
intravascular EIS using a linear 4-electrode conﬁgura-
tionmicroelectrode (2 9 105 lmin length).30Our group
further reduced the sensor surface area by 2000-fold
using the concentric bipolar microelectrode sensors
(300 lm in diameter)4,35 and introduced the balloon-
inﬂatable bipolar electrodes tomeasureEIS signals from
non-homogeneous tissue composition, non-planar
endoluminal surface, and non-uniform electric current
distribution of the atherosclerotic lesions.4
We hereby introduce a 2-point conﬁguration to
avoid separate current paths and common-mode sig-
nals that confound measured data.14 The 2-point con-
ﬁguration with ﬂexible round electrodes (B 240 lm,
Fig. 1) enabled deep intraplaque penetration by AC
current, allowing for quantiﬁcation of oxLDL-rich
plaque from the thoracic to distal abdominal aortas in
the NZW rabbit model. We biased an input peak-to-
peak AC voltage of 50 mV and a sweeping frequency
from 10 to 300 kHz to the 2-point electrodes. We
quantiﬁed and validated EIS signals both in vivo and
ex vivo in relation to epicardial fat tissue, and recapit-
ulated the frequency range from 10 to 300 kHz in which
distinct capacitive and phase changes revealed low,
intermediate and high oxLDL-rich lesions. Thus, we
demonstrated a simpliﬁed 2-point electrode design to
enhance detection of lipid-laden plaques.
MATERIALS AND METHODS
EIS Sensor Deployment, Device Assembly and
Microfabrication
We fabricated an EIS sensor with several micro-
electrodes in an array (Fig. 1a). In the present study,
we always utilized the same 2 middle electrodes high-
lighted with red circles. We present a 3D rendering of
the deployment of our EIS sensor with the balloon in
grey, plaque in green and vessel wall segment in blue
(Fig. 1b). This is followed by a 2D side-view of the
device showing where the microelectrodes are placed
and a 2D cross-sectional view of the device in contact
with an atherosclerotic plaque segment with electric
ﬁelds generated between the microelectrodes.
A 20 cm long plastic catheter with a dilatation
medical balloon (Vention Medical, NH) sleeved on
from one end was used for in vivo delivery of the sen-
sor, while the other end was connected with a
mechanical pump to control the balloon dilatation.
Miniature holes were punched on the catheter sidewall
covered by the balloon for air delivery (Fig. 1b). The
ﬂexible sensor, after connecting the contact pads with
metal wires using conductive epoxy, was ﬁxed on the
surface of the balloon by silicone adhesive (Henkel,
CT). An insulating heat-shrink tube was used to wrap
the wires and secure their positions alongside the ca-
theter. These wires are conveniently connected with
normal electrical cables to interface with measuring
instruments as illustrated by the assembled EIS sensor
with close-up view showing the ﬂexible electrodes at-
tached on the balloon.
The fabrication process of the ﬂexible EIS sensors
started with a parylene-C (PAC) thin ﬁlm (5 lm)
deposition onto a normal silicon wafer treated with
hexamethyldisilazane (HMDS, 3 min) for adhesion
promotion (Fig. 1c). Subsequently, a layer of Au/Ti
(200 nm/20 nm) was deposited and selectively removed
through chemical wet etching based on a lithographi-
cally-deﬁned pattern. Another layer of PAC (5 lm)
was deposited as an insulating barrier, followed by
exposure of the sensing electrodes and contact pads
area via reactive ion etching (RIE). The ﬁnal device
footprint was deﬁned by further etching through the
PAC thin ﬁlm. The PAC sensor was peeled off from
the wafer and used for assembly.
Equivalent Circuit Diagram for the Paired Electrode
Sensor
The current design can be modeled with the fol-
lowing equivalent circuit to demonstrate the constant
phase element (CPE) in association with non-ideal
double layer capacitance at the electrode/tissue inter-
face (Fig. 2a). The electrode-tissue interface impedance
of both sensing electrodes is considered as a constant
phase element:
ðCPEÞZCPA ¼ 1
YðjxÞa ; ð3Þ
where Y denotes the nominal capacitance value, and a
is a constant between 0 and 1, corresponding to non-
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ideal interface effects. The impedance of measured
tissue is modeled as paralleled RT and CT, representing
both resistive and capacitive elements within the tissue,
depending on material composition and structural
variation. Moreover, the Bode plot of the equivalent
circuit model is depicted based on a network analysis
FIGURE 1. (a) Design schematic of an array of individually addressable impedance sensing electrodes. A set of eight round
electrodes (B 240 lm) was implemented. The electrode pair situated in the center (400 lm separation) and highlighted in red was
selected for measurements throughout the study. (b) 3D rendering of the deployed EIS sensor in contact with a plaque, and 2D
side-view of the device illustrating microelectrode placement with adjacent 2D cross-sectional view illustrating apposition and
contact of the electrodes on the inflated balloon with the endoluminal surface covering an atherosclerotic plaque. Generated
electric fields between the 2 microelectrodes are illustrated. An image of the actual EIS sensor with close-up view of flexible
electrodes attached on the inflated balloon is provided. (c) Schematics of the microfabrication process of the flexible PAC
electrodes (i–iv).
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similar to Grimnes et al.14 (Fig. 2b). The values of each
electrical component in the Bode plot are adapted from
our previous study34 and are as follows: Y = 100 nS,
RT = 1 kX, CT = 10pF, a = 0.8. As illustrated, the
phase gradually rises towards zero degree as the fre-
quency increases, indicating a diminishment in the
interfering capacitive effect within the system, partic-
ularly at the electrode/tissue interface. Hence, im-
pedance values at higher frequencies have a superior
ability to reveal the distinctive characteristics of
interrogated samples.
Animal Studies
All animal studies were performed in compliance
with the IACUC protocol approved by the UCLA
Oﬃce of Animal Research. Rabbit experiments were
conducted in the UCLA translational research imaging
center (TRIC) lab. Analyzes were conducted in n = 5
control rabbits fed a chow diet and n = 3 age-matched
high-fat fed NZW male rabbits.26 High-fat animals
were placed on a 1.5% cholesterol and 6.0% peanut oil
diet (Harlan laboratory) for 9 weeks prior to harvest-
ing. Animals were anesthetized with isoﬂuorane gas,
endotracheally intubated and placed on a mechanical
ventilator. Blood pressure and heart rate were moni-
tored continuously by a non-invasive paw cuff as well
as an intra-arterial sensor. A femoral cut-down was
performed and a 4-French arterial sheath placed in
the common femoral artery. Under ﬂuoroscopic
guidance (Siemens Artis Zeego with robotic arm) and
iodinated contrast dye injection, the EIS sensor was
advanced to the abdominal aorta for live interroga-
tion. In vivo and ex vivo measurements were obtained
in the abdominal aorta between the renal artery
bifurcation and also proximal to the aortic bifurca-
tion. Following animal harvesting, ex vivo measure-
ments were conducted in various segments with
differing levels of lipid burden in the descending
thoracic aorta and abdominal aorta at the level of the
renal arteries. Three replicates were performed at each
interrogation site. Thus, for each animal, measure-
ments were obtained at 3 anatomic sites: (1)
descending thoracic aorta, (2) abdominal aorta at the
level of the renal arteries, and (3) abdominal aorta
proximal to the aortic bifurcation. In the high-fat fed
animals, these 3 anatomic sites correspond to areas
with: (1) severe plaque, (2) moderate plaque, and (3)
mild plaque, respectively. AC signals with peak-to-
peak voltages of 50 mV and frequencies ranging from
1000 Hz to 300 kHz were delivered at each site. The
impedance magnitude and the phases of the im-
pedances were acquired at 10 data points per fre-
quency decade.
EIS Measurements in Aortas
Angiograms were obtained during ﬂuoroscopy to
document vessel anatomy and verify appropriate
advancement of the EIS sensor. Measurements were
obtained in control rabbit aortas and in various seg-
ments of the high-fat fed rabbit aortas. Diﬀerent
anatomical segments exhibited varying degrees of
atherosclerosis, with the most prominent being the
thoracic aorta. Segments that were analyzed were the
descending thoracic aorta (severe plaque), abdominal
aorta at the level of the renal artery bifurcation
(moderate plaque), and abdominal aorta proximal to
the aortic bifurcation (mild plaque). Results were
compared to plaque burden as assessed by lipid con-
tent and inﬂammatory activation by macrophage. The
catheter-based balloon-inﬂatable EIS sensor was de-
ployed in vivo. The balloon was inﬂated to 10 psi
(pounds per square inch) to allow for optimal endo-
luminal contact.
FIGURE 2. (a) Equivalent circuit diagram for the paired
electrode sensor. a: constant between 0 and 1, corresponding
to non-ideal interface effects between electrodes and tissues.
CE counter electrode, WE working electrode, CPE constant
phase element. Y nominal capacitance value, RT resistive
element, CT capacitive element. (b) The Bode plot for the
equivalent circuit model with component values: Y 5 100 nS.
RT 5 1 kX. CT 5 10 pF. a 5 0.8.
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Microfabrication and Deployment of High-Frequency
IVUS
PbMg1/3Nb2/3O3-PbTiO3 (PMN-PT) single crystal,
with its superior piezoelectric properties, served as the
functional element of the IVUS transducer used in this
study.19 The general fabrication process previously
reported was modiﬁed to fabricate the four-layered
IVUS transducer.24 The IVUS transducer was then
inserted into customized probe housing (a stainless
steel tube one window; OD: 1 mm; length: 2 mm). The
coaxial cable was covered by the ﬂexible torque coil to
ensure accurate and smooth translation of torque to
the distal end over a large distance and through tor-
tuous curves. During experiments, the probe was in-
serted into a sheath to avoid cross-contamination
between probe and arterial segments. Saline solution
was ﬁlled in the sheath before experiments. For the
IVUS imaging system, a Panametrics PR5900 pulser/
receiver (Olympus NDT, Kennewick, WA) was used
for pulse generation and signal detection with 26 dB
gain and 10–100 MHz band-pass ﬁlter. The ultrasonic
radio frequency data was fed into the 12 bit digitizer
and digitized at a sampling rate of 400 MHz. The
acquired IVUS signal was processed, displayed and
saved simultaneously by custom built software.23 The
system has a frame rate of 20 frames per second with
1000 A-lines per frame. A custom built rotary joint
device was used for motion control and signal coupling
from the rotational part to the stationary part. All
these components were ﬁxed to a translational stepper
motor with pull-back capability. To evaluate the gen-
eral performance of the IVUS transducer and imaging
system, the pulse-echo testing was performed. The
measured center frequency of the IVUS transducer was
39 MHz with a fractional bandwidth of 45%.
Histology
A portion of each aorta was ﬁxed in 4%
paraformaldehyde, embedded in paraﬃn and serially
sectioned at 5 lm for histological analyzes. Lipids were
identiﬁed by hematoxylin and eosin staining and
macrophages by F4/80 staining (monoclonal rat anti-
mouse antibody, Invitrogen).
Statistical and Correlation Analyzes
Statistical analysis was performed using analysis of
variance with multiple comparisons adjustment for this
study design. Since the assumption of homogeneity of
variance was violated as evidenced by a signiﬁcant
Levene’s test18 in most cases, the Brown-Forsythe test2
was systematically used to determine signiﬁcance
across groups. Dunnett’s test9 was used for multiple
comparisons given this statistical approach does not
depend on homogeneity of variances and corrects for
multiple testing. IBM SPSS version 20 was used to
perform the analysis. A p value <0.05 was considered
signiﬁcant. Spearman’s correlation was determined as
follows:
r ¼ 1 6Rd
2
i
nðn2  1Þ ; ð4Þ
where r = Spearman correlation, di = difference
between ranks, n = sample size.
RESULTS
EIS Measurements by the 2-Point Conﬁguration
The catheter-based balloon-inﬂatable 2-point con-
ﬁguration was deployed in vivo. The frequency sweep
revealed similar impedance proﬁles in the frequency
range 1–10 kHz, consistent with a more resistive pat-
tern in tissues (Fig. 3a). However, signiﬁcant differ-
ences in impedance appeared in the frequency range
10–300 kHz, consistent with a more capacitive behav-
ior of the arteries (p< 0.05, Brown-Forsythe test). The
EIS measurements revealed a baseline impedance of
12 kX at 10 kHz, 5.6 kX at 100 kHz, and 5.2 kX at
300 kHz in control arteries. EIS increased in the
presence of oxLDL-rich lesions. At an intermediate
frequency of 10 kHz, the magnitude of the impedance
increased to 12.5, 13, and 14 kX in the abdominal
aorta with mild plaque, the abdominal aorta at the
renal artery bifurcation with moderate plaque and the
descending thoracic aorta with severe plaque, respec-
tively. At a high frequency of 300 kHz, the magnitude
of the impedance increased further to 5.9, 7, and
8.4 kX in arterial segments with mild, moderate and
severe plaque, respectively. As a corollary, a decrease
in phase was observed in the lower frequency range,
indicating a longer delay between voltage input and
current output which progressively increased in the
higher frequency range (p< 0.05 from 1.5 to 125 kHz,
Brown-Forsythe test) (Fig. 3b). Ex vivo studies were
conducted in explanted aortic segments, demonstrating
a high correlation with in vivo measurements with a
Spearman r = 0.9732 (p< 0.0001) (Fig. 3c). Thus, the
2-point conﬁguration allowed for EIS measurements to
quantify the degrees of plaque burden.
Validation with Intravascular Ultrasound (IVUS) and
Immunohistochemistry
To validate the EIS measurements, we performed
IVUS and histology to assess the underlying
atherosclerotic lesions. Visualization of atherosclerotic
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plaques of varying burden was performed by IVUS
to conﬁrm underlying plaque severity (Fig. 4a, b).
The IVUS and EIS measurements were not obtained
simultaneously, but sequentially with different ca-
theters to avoid interference between the two trans-
ducers. Atherosclerotic plaques were further
identiﬁed by hematoxylin and eosin (H & E) stain-
ing, and the oxLDL-laden macrophage/foam cells
were detected by F4/80 immunohistochemistry
staining (Figs. 4c–4j) to support the elevated EIS
values (Fig. 3a). Control aortas were free of oxLDL-
rich lesions or macrophages, validating the low EIS
values (Fig. 3a).
EIS Measurements of Epicardial Fat Tissue in
Comparison with Aortic Segments
To further characterize the 2-point conﬁguration,
we obtained EIS measurements from ex vivo epicardial
fat tissue and compared these to aortic segments
(Fig. 5). No differences were observed in epicardial fat
tissue between control and high fat fed animals. Im-
pedance proﬁles were signiﬁcantly higher in epicardial
fat tissue compared to aortic segments throughout the
frequency sweep from 1 to 300 kHz (p< 0.05, Brown-
Forsythe test). Post-hoc multiple testing analyzes fur-
ther illustrated signiﬁcant differences between control
aortas and combined atherosclerotic plaque segments
from 10 to 300 kHz (p< 0.05, Dunnett test). These
ﬁndings corroborate the capability of the simpliﬁed 2-
point conﬁguration to distinguish tissues exhibiting
varying lipid burden by intravascular EIS measure-
ments.
Two-Point Electrode Conﬁguration
One of the critical issues for the 4-point EIS design
is the existence of the negative sensitivity ﬁeld.14 The
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FIGURE 3. (a) Impedance magnitude in control aortas and aortic segments with mild, moderate and severe plaque are depicted in
logarithmic scale. P< 0.05 in the frequency range 10–300 kHz for impedance profiles, Brown–Forsythe test. Data presented as
means 6 standard errors of the mean. (b) Phase spectra in control aortas and aortic segments with mild, moderate and severe
plaque are depicted in logarithmic scale. P< 0.05 in the frequency range 1.5–125 kHz for phase spectra, Brown-Forsythe test. Data
presented as means 6 standard errors of the mean. (c) In vivo vs. ex vivo correlation of impedance spectra obtained from identical
aortic segments with the EIS sensor. Spearman test r 5 0.9732, p< 0.0001.Figure 3 (a) - the x and y axes lines are missing.
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formulation of the sensitivity ﬁeld (S) of a tetrapolar
conﬁguration has been detailed in previous works13
and can be written as
S ¼ J1  J2
I2
; ð5Þ
where J1 and J2 are the current density at the current
injection electrode pair and the voltage measuring
electrode pair, respectively, and I denotes the actual
current being injected.
As seen in Eq. (5), the dot product of J1 and J2 can
possibly become a negative value in certain regions of
the targeted tissue, indicating a reverse correlation
between the local conductivity change within the tissue
and the overall impedance value. Consequently, the
impedance measurement can no longer genuinely rep-
resent the real local conductivity variation and thus
fails to recognize regions of different plaque severity.
Once shifted to a 2-point design, J1 and J2 represent
the same current density ﬂowing across the two elec-
trodes in use and the dot product between the two will
always remain positive.
We have highlighted characteristics of EIS sensors
with diﬀerent numbers of electrodes in Table 1, and
illustrate lower maximum relative variability (deﬁned
as standard deviation/mean), an indicator of higher
SNR, with the current sensor design. Compared to the
concentric design, the 2-point conﬁguration generated
a higher SNR for its high common mode rejection
ratio (CMRR) as a result of symmetrical electrode-
tissue contact area. In addition, under the same input
current, the electrode pair with larger separation (2-
point) provides a higher electrical potential (higher
resistivity due to larger dimension) allowing penetra-
tion into the deeper tissues with robust signals, ren-
dering the data more reliable. We compare the
previous concentric design with the current design in
terms of input voltage, sweeping frequency, impedance
and maximum relative variation in Table 2. EIS by 2-
point conﬁguration was most sensitive in detecting
vascular tissue compositions at 10–300 kHz while the
concentric bipolar conﬁguration was sensitive at 100–
300 kHz.
The 2-point design further reduces the number of
unknown variables from 6 to 4 in the equivalent cir-
cuit,35 reducing simulation and calculation. The 4 un-
known variables required in both the 2-point and
concentric bipolar designs are: (1) resistive and (2)
capacitive elements of the tissue as represented by: RT
and CT, the constant phase element of the electrode-
tissue interface in the counter electrode (CE):
ZCPA ¼ 1YðjxÞa, where (3) Y denotes the nominal
capacitance value, and (4) a the constant of the surface
property of the electrodes ranging from 0 to 1 corre-
sponding to non-ideal interface effects. The additional
2 unknowns speciﬁc to the previous concentric design
are (1) double layer capacitance CDL2 and (2) charge
FIGURE 4. Example of intravascular ultrasound measure-
ments obtained in a control aorta (a) and from a segment with
atherosclerotic plaque (b). The yellow arrow is pointing to-
wards the atherosclerotic plaque. Histologic analysis of con-
trol aortas at 34 (c) and 310 (d) magnification demonstrate
absence of subendothelial lipid deposits, whereas suben-
dothelial lipid content characteristic of plaques in
atherosclerotic lesions (black arrows) are readily identified in
animals fed a high fat diet at 4x (e) and 10x (f). Immunohis-
tochemical analysis of macrophage infiltration demonstrates
their absence in control aortas at 34 (g) and 310 (h) whereas
a robust presence (green arrows) is documented in
atherosclerotic aortic segments from animals fed a high fat
diet at 34 (i) and 310 (j). Yellow arrows: plaque identified by
IVUS. Black arrow: plaque identified by histology. Green ar-
rows: macrophages identified by immunohistochemistry.
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transfer resistance,RCT2, both arising from working
electrode-tissue interface.
DISCUSSION
The main contribution to endoluminal assessment
of atherosclerotic plaque we present is the design and
fabrication of balloon inﬂatable 2-point electrodes for
EIS measurements of oxLDL-rich plaque. We char-
acterize the stretchable sensors in terms of distinct
changes in impedance and phase spectra in response to
balloon inﬂation pressure. Our 2-point approach rep-
resents an advancement to the previously proposed
linear 4-point electrode arrays,28–30 which preclude
detection of small and non-homogeneous lesions.
Thus, we demonstrate a simpliﬁed 2-point electrode
conﬁguration to advance the electrochemical im-
pedance measurements for intraplaque lipid-laden le-
sions.
Atherosclerosis is a chronic inﬂammatory disease
with involvement of both innate and adaptive immune
pathways.21 The atherosclerotic plaque involves a
complicated interplay between lipid metabolism,
inﬂammation, macrophage activation and collagen
breakdown, and the rupture of atherosclerotic plaques
remains a leading cause of mortality in developed
countries.20 Currently, fractional ﬂow reserve (FFR),
IVUS or optical coherence tomography (OCT) are
limited to anatomic and hemodynamic characteristics
of atherosclerotic plaques.1 Despite the advent of
computerized tomographic (CT) angiography, high
resolution magnetic resonance imaging (MRI),31
intravascular ultrasound (IVUS), near-infrared ﬂuo-
rescence (NIRF),15 and time-resolved laser-induced
ﬂuorescence spectroscopy,25 real-time interrogation of
metabolically active, lipid-rich plaques remains an
unmet clinical need. However, none of the above
modalities assess intraplaque lipid and oxidized LDL
content as has been proposed with EIS. Importantly,
oxidized low density lipoprotein (oxLDL) induces
transformation of macrophages to lipid-laden foam
cells.3 Furthermore, growing evidence supports that
oxLDL and thin-cap ﬁbroatheromas (TCFA) rich in
macrophage/foam cells are prone to mechanical stress
and destabilization.8,11,37 Others and our group have
further demonstrated the hemodynamic shear forces
on metabolically active lesions in athero-prone
regions.32,35 The safety and relatively simple deploy-
ment of an invasive EIS sensor merit further consid-
eration in experimental and translational studies,
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FIGURE 5. Representation of combined EIS impedance
spectra from aortas and epicardial fat. Control aortas,
atherosclerotic aortas displayed as the mean value of all
analyzed segments from various levels of the arterial tree and
superimposed profiles of epicardial fat tissue demonstrate
stark contrasts in EIS profiles and tissue impedance signa-
tures across the frequency sweep. P< 0.05 throughout the
frequency sweep from 1–300 kHz in epicardial fat tissue
compared to aortic segments, Brown–Forsythe test. P< 0.05
between control aortas and combined atherosclerotic plaque
segments in the frequency range 10–300 kHz, Dunnett
test.Figure 5 - the x axis line is missing
TABLE 1. Comparison of EIS sensors with different numbers of electrodes. Maximum relative variability: standard deviation/
mean.
Reference Design Sample condition Input voltage (mV) Sweeping frequency (Hz) Impedance (X) Maximum relative variability
Yu et al.36 3-point In vitro 10 0.1–300 k 20–500 k ~0.15
Streitner et al.29 4-point In vitro 10 1, 10, 100 k 0.3–1 k ~0.25
Presented work 2-point In vivo 50 1–300 k 4–60 k ~0.1
TABLE 2. Comparison of different 2-point EIS sensors. Maximum relative variability: standard deviation/mean.
Reference Design Sample condition Input voltage (mV) Sweeping frequency (Hz) Impedance (X) Maximum relative variability
Yu et al.35 Concentric In vitro 10 10–100 k 1.1–2.1 k ~0.1
Cao et al.4 Concentric In vivo 10 1–300 k 7–100 k ~0.1
Presented work Linear In vivo 50 1–300 k 4–60 k ~0.1
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either alone or combined with other invasive modali-
ties such as IVUS.
When comparing our 2-point sensor with previous
3-point and 4-point linear arrays (Table 1), the maxi-
mum relative variability was higher (i.e. more vari-
ability and hence less stable EIS results) by 50% in 3-
point sensors and by 150% in 4-point sensors. In
addition, when comparing our linear 2-point sensor
with the concentric bipolar electrodes (Table 2), the
maximum relative variability was the same, however
the major advances of the current 2-point design allow
for deep tissue penetration for intraplaque burden
assessment (Fig. 1b). The spacing between the two
concentric electrodes was 100 lm, conﬁning current
traveling to the ﬁbrous cap area; whereas the spacing
between the 2-point round electrodes is 400 lm,
allowing for deep current penetration in the frequency
band 10–100 kHz with high SNR.
Also, the contact impedance between the two con-
centric bipolar electrodes varies due to the diﬀerent
electrode area, giving rise to diﬀerent voltage drops at
each double layer and introducing common mode
noise into the detected signal. This reduction in noise
rejection capacity results in a decrease in SNR.
Moreover, the 2-point design reduced the unknown
variables from 6 for the concentric bipolar electrodes
to 4 as simulated by the equivalent circuit (Fig. 2).
Our ﬂexible and 2-point electrodes were mounted on
an inﬂatable balloon for endoluminal EIS quantiﬁca-
tion of lipid burden. EIS quantiﬁes the intrinsic elec-
trochemical properties of tissues; namely water
content, electrolyte concentration, vascular calciﬁca-
tion and cholesterol/lipid content which inﬂuence the
changes in impedance. Sites of mild, moderate and
severe atherosclerotic plaque burden in previously de-
scribed speciﬁc segments of the aorta16 were veriﬁed by
ﬂuoroscopy and IVUS for gross anatomy, by histology
for lipid presence, and by immunohistochemistry for
foam cells or macrophages. We applied AC current to
the lesions and recorded impedance, Z, to determine
electrochemical properties. EIS takes advantage of the
vascular tissues that store and dissipate charges.4,34–36
In addition to the capability of EIS to differentiate
oxLDL-rich from oxLDL-free lesions34,36 we further
demonstrated that endoluminal EIS signals are inde-
pendent of blood viscosity and ﬂow rate as evidence by
the high Spearman correlation between in vivo and
ex vivo EIS signals (Fig. 3c). Of note, the overall 3D
geometry of vessels undergoes changes due to the loss
of residual stresses during resection, leading to some
modiﬁcation in the endoluminal area over which
stretchable sensor apposition was performed and im-
pedance interrogation conducted. Despite this limita-
tion, we observed a highly signiﬁcant correlation
between in vivo and ex vivo measurements. EIS signals
of epicardial fat with a distinct impedance spectrum
further support our 2-point design to quantify lipid-
rich tissues.
Intravascular EIS assessment by deployment of
linear 4-point microelectrode array (2 cm long) via
balloon catheter was demonstrated in NZW rab-
bits.17,29,30 To address EIS signals in human coronary
arteries, we previously designed concentric microelec-
trodes (300 lm in diameter) that were conformal to the
non-planar endoluminal surface and non-uniform
electric current distribution. Distinct from the large
surface area of the 4-point design, the concentric
bipolar microelectrodes afforded a 2000-fold reduction
in size for intravascular deployment in the mice and
rabbit models.35 To further simplify the concentric
bipolar design for EIS interrogation in humans, we
have re-conﬁgured to a 2-point, paired electrode design
(highlighted in Fig. 1a). Compared to the concentric
design,4 2-point conﬁguration provides a larger sepa-
ration between the electrode pair (400 lm), allowing
for deep current traveling into the intraplaque lipid
core to achieve signiﬁcant tissue impedance disparities.
Moreover, these symmetric electrode pairs provide a
common mode rejection capability to reject the un-
wanted input signals from the wanted difference sig-
nals.
The gold paired electrodes are well embedded in a
layer of insulating PAC ﬁlm to minimize current drift
and cross-talks (Fig. 1). The limited exposed areas for
endoluminal contact circumvent potential short circuit.
The EIS measurement is conducted at room tempera-
ture within the operating range in the Gamry system
(0–70 C) to prevent current drifts. To predict the
potential cross-talk (parasitic capacitance), we per-
formed the open circuit impedance, ZP, measurement
between the two metal wires to have a quantitative
estimation of the potential parasitic capacitance CP.
(ZP ¼ 1jxCP; see Fig. 6). Impedance values arising from
the parasitic capacitance is on the order of 10 kX at
~300 kHz in comparison with the measured tissue
impedance of 1 kX at ~300 kHz. For this reason, the
equivalent impedance of parasitic capacitance is 10
times the measurement impedance, minimizing current
drift and cross-talk under physiologic conditions.
The high-frequency range indicates that real-time
EIS quantiﬁcation with the decreased phase delay
supports the reliable intravascular strategy. An
inductor circuit was used for voltage application and
subsequent current generation to quantify plaque
burden. When inductors (or capacitors) are involved in
an AC circuit, the peaks in voltage and current are not
synchronized. The fraction of a period diﬀerence
between the peaks expressed in degrees is the phase
diﬀerence of £90. Our data indicate that there was a
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signiﬁcant phase delay of ~270 in the low frequency
range and a decrease in phase delay to ~210 in the
highest frequencies. As a result, high frequency range
shortens the duration of time lag between voltage
application and current generation. The EIS im-
pedance proﬁles obtained were signiﬁcantly diﬀerent
over the 10–300 kHz frequency sweep, with high im-
pedance in the severe plaque area of the descending
thoracic aorta, intermediate impedance in the moder-
ate plaque area of the proximal abdominal aorta, and
low impedance in the mild plaque area of the distal
abdominal aorta. These results support the application
of EIS to quantify intraplaque lipid burden in real
time. Previous histological analysis of aortic
atherosclerosis in the rabbit model agreed with severe,
moderate, and mild degrees of lipid burden in the
thoracic, proximal abdominal and distal abdominal
aorta, respectively.16
Flexible electronics is an emergent intravascular
approach for pre-clinical models. Surface ﬂexible hy-
brid electronics embedded in Polydimethylsiloxane
(PDMS) and adhered to the skin have been tested for
electrocardiogram and temperature monitoring.33
Implantable ﬂexible electrode arrays have been
embedded in Parylene C (PAC) for its bio-compati-
bility6 and investigated for retina implants to restore
vision.7 We have quantiﬁed the Young’s modulus, or
elastic modulus, deﬁned as the ratio of stress to strain
of the stretchable paired microelectrodes mounted on
inﬂatable balloons.4 Since the Young’s modulus of
nylon for the balloon is 2.7–4.8 GPa,12 matching with
that of PAC (3.2 GPa)22 to minimize strain mismatch,
the 2-point electrodes afﬁxed onto the non-compliant
balloon (Venture Medical, USA) withstood the in-
ﬂated balloon at 10 pounds per square inch (psi) or
~69 kPa for optimal endoluminal contact. In fact, the
applied stress at 10 psi was well below the tensile
stress at 58 MPa of PAC. Furthermore, the Young’s
modulus of the blood vessel ranges from 0.2 to
0.6 MPa10 resulting in <35% deformation in the
normal direction of blood ﬂow. Thus, the ﬂexible and
stretchable 2-point design provides safe endoluminal
contact.
Our 2-point sensor discriminates areas with no
plaque (controls), mild plaque (abdominal aorta
proximal to the aortic bifurcation), moderate plaque
(abdominal aorta at the level of the renal arteries) and
severe plaque (descending thoracic aorta), thereby
detecting by EIS observations previously made by
histology in experimental rabbits.16 In humans, the
intravascular assessment of coronary arteries with
differing levels of intraplaque lipid burden has reached
clinical use.1 Additional studies in humans have
established that plaques with larger lipid and oxLDL
area are more prone to vulnerability and rupture with
ensuing clinical events such as myocardial infarction.11
These comparisons with pathology observations in
humans provide the basis for future studies to establish
the ability of EIS to distinguish stable from vulnerable
atherosclerotic plaques.
In conclusion, the 2-point EIS design represents a
diagnostic and preventive strategy to identify lipid-rich
plaques for targeted therapy and for longitudinal fol-
low-up in response to pharmacological intervention.
We demonstrate a new generation of balloon-inﬂat-
able 2-point microelectrodes as a simple, reliable, safe
and robust approach to complement diagnostic
angiography. Our ﬁndings provide a basis for future
pre-clinical studies to determine the EIS sensor either
as a stand-alone catheter or packaged with other
modalities such as IVUS.1
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FIGURE 6. Open circuit measurement of impedance magni-
tude (a) and phase spectra (b) between the two metal wires
allows a quantitative estimation of the potential parasitic
capacitance. Impedance values arising from the parasitic
capacitance are on the order of 10 kOhm at 300 kHz.
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